Drawing for NEUDIVE

USPTO serial 79413062

NEUDIVE

Reviewed by CopyMark Law Group

Reg. 8072767Status 700Registered
Filing date
Status date
Registration date
Dec 23, 2025
Examiner
KEY,THOMAS S
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with NEUDIVE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Minchul Yang

Minchul Yang STIP Law Group, LLC40 W. Chesapeake Ave, Suite 506Towson, MD 21204United States

Goods and services

ClassDescriptionStatusFirst use
009Software as a Medical Device (SaMD), downloadable, for diagnosing and treating cognitive disorders, attention deficit disorders, dementia, and neurocognitive conditions through digital therapeutics; Downloadable Software as a Medical Device (SaMD) for remote monitoring of cognitive function and behavioral patterns for medical diagnosis and treatment of neurocognitive disorders; downloadable computer software for wireless content delivery; downloadable virtual reality game software; computer game software, recorded; downloadable educational software for cognitive assessment and training for medical and therapeutic purposes; teaching robots; audiovisual teaching apparatus being downloadable education software and downloadable virtual reality software for cognitive rehabilitation therapy; data processing apparatus; humanoid robots having communication and learning functions for assisting and entertaining peopleACTIVE—
044Telemedicine services; remote monitoring of medical data for medical diagnosis and treatment; medical clinic services; medical advice for persons with disabilities; mental health services; cognitive therapy services; cognitive rehabilitation therapy services; digital therapeutic services for cognitive disorders; rehabilitation for substance abuse patients; hospital services; ADHD screening services; learning disability screening servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 23, 2026FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jul 2, 2026FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jul 2, 2026FIMPFINAL DISPOSITION PROCESSED—
Jun 11, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
May 25, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
May 25, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Mar 23, 2026FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Dec 23, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Dec 23, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 4, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 4, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 29, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 3, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 1, 2025XAECEXAMINER'S AMENDMENT ENTERED—
Oct 1, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 1, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 1, 2025CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 23, 2025RFNTREFUSAL PROCESSED BY IB—
Aug 15, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 15, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 15, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 2, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Aug 2, 2025RFRRREFUSAL PROCESSED BY MPU—
Jun 13, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 12, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 8, 2025RFWRNON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW—
Apr 4, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Apr 3, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 2, 2025DOCKASSIGNED TO EXAMINER—
Dec 30, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 30, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 26, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance